Packaging needs to be taken into account
I read with interest the online research article on the package user test (PJ, 21/28 June 2014, p648).
Although the research that has been done on the packaging issue is a step in the right direction, I believe the variation of packaging of the same product should also be taken into account. Patients also use packaging colour and design as a method of identification. Even shape can be a factor especially if patients are used to using a specific brand for a long time.
For years there has been debate about manufacturers getting their heads together and sorting out pack sizes of 28 or 30 days. Now I believe they also need to get together to form a consensus on package design and formulation. When it comes to warfarin, everyone can distinguish the three main strengths from the package or the tablets, irrespective of brand. Why does this not apply to other medicines?
Isle of Man
Citation: The Pharmaceutical Journal URI: 20065631